Search research articles

Search research articles

Related Experiment Videos

Conus toxins: targets and properties.

Christine E Heading¹

¹The Open University, Department of Biological Sciences, Walton Hall, Milton Keynes, MK7 6AA UK. moore11@globalnet.co.uk

Idrugs : the Investigational Drugs Journal

|November 20, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gender issues and the pharmacotherapy of substance abuse.

IDrugs : the investigational drugs journal·2008

Same author

Drug evaluation: CYT-002-NicQb, a therapeutic vaccine for the treatment of nicotine addiction.

Current opinion in investigational drugs (London, England : 2000)·2007

Same author

Vivitrex (Alkermes/Cephalon).

Current opinion in investigational drugs (London, England : 2000)·2006

Same author

NicVAX (Nabi Biopharmaceuticals).

IDrugs : the investigational drugs journal·2003

Same author

Recent advances against substance abuse.

IDrugs : the investigational drugs journal·2003

Same author

TA-CD. Xenova.

IDrugs : the investigational drugs journal·2003

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Conus snail venoms contain numerous potent peptides targeting mammalian ion channels. These conopeptides offer therapeutic potential for nervous system disorders but face bioavailability and toxicity challenges.

Area of Science:

Marine Biology
Neuropharmacology
Biochemistry

Background:

Conus snail venoms are a rich source of bioactive peptides, known as conopeptides.
These peptides exhibit high specificity for mammalian receptor sites, particularly ion channels.
The diversity of Conus species (~500) suggests a vast repertoire of conopeptides.

Purpose of the Study:

To explore the therapeutic potential of conopeptides derived from Conus snail venoms.
To identify the specific receptor targets of conopeptides within the mammalian nervous system.
To address challenges related to the development of conopeptide-based therapeutics.

Main Methods:

Analysis of Conus snail venom composition.
Characterization of conopeptide interactions with ion channels (voltage-gated, ligand-gated, G-protein linked).

Related Experiment Videos

Investigation of potential physiological targets in the central and peripheral nervous systems.

Main Results:

Conopeptides demonstrate potent specificity for various mammalian ion channels.
Identified targets include voltage-gated, ligand-gated, and G-protein linked ion channels.
Central nervous system targets are prominent in advanced therapeutic development.

Conclusions:

Conus snail venoms represent a significant resource for novel neurotherapeutics.
Conopeptides targeting the central nervous system hold promise but require overcoming bioavailability and toxicity issues.
Further research is needed to optimize conopeptide delivery and safety for therapeutic applications.